Ontogeny Of Toll (TLR) Function In Normal And Allergic Children: The Impact Of Microbial-rich Environments
Funder
National Health and Medical Research Council
Funding Amount
$387,489.00
Summary
Reduced exposure to bacteria during early life has become a leading candidate to explain the escalating rate of allergic disease. Despite this, the development and maturation of the pathways involved in normal recognition of bacteria in children has not been explored. In this proposal we set out to address this critical shortcoming in both normal and allergic children. Mapping normal maturation of such pathways will help us to identify better early markers of allergic disease.
Combination Immunotherapeutic Strategies For Haematological Cancers
Funder
National Health and Medical Research Council
Funding Amount
$421,747.00
Summary
Patients with lymphoma cancers initially respond well to treatment, but later relapse with disease. The immune system can be effective at controlling cancer. A potential treatment option is to boost the natural immune response against cancer. This study investigates a novel vaccine that activates a certain immune cell, NKT cells, to fight lymphomas by delivering an NKT cell-activating molecule. Outcomes will allow assessment of combining an NKT-based vaccine with established treatments for lymph ....Patients with lymphoma cancers initially respond well to treatment, but later relapse with disease. The immune system can be effective at controlling cancer. A potential treatment option is to boost the natural immune response against cancer. This study investigates a novel vaccine that activates a certain immune cell, NKT cells, to fight lymphomas by delivering an NKT cell-activating molecule. Outcomes will allow assessment of combining an NKT-based vaccine with established treatments for lymphoma.Read moreRead less
Understanding Immunosuppressive Pathways In Cancer
Funder
National Health and Medical Research Council
Funding Amount
$419,178.00
Summary
Cancer-induced immune suppression is a major obstacle to the effective treatment of many cancers. Suppression can be mediated by cells of the immune system, or cancers themselves. My project aims to investigate 3 suppressive pathways and determine their hierarchy in different mouse models of cancer using mouse genetics and antibody-based treatment approaches. Understanding these processes ongoing in the cancer environment will allow the design of more effective cancer therapies.
Characterisation Of The Genetic Networks Underlying Macrophage Differentiation And The Resolution Of Inflammation
Funder
National Health and Medical Research Council
Funding Amount
$405,000.00
Summary
Chronic inflammation is a central player in many common diseases, impacting on the health and well being of millions of Australians. By using innovative genomic approaches to build a map of all of the gene products involved in the inflammatory process, this project aims to identify which are the critical molecules that normally switch off inflammation. Our ultimate aim is to develop new approaches to treating inflammatory disease.
Diet And Mental Health: Translating New Knowledge Into Innovative Prevention And Treatment Strategies
Funder
National Health and Medical Research Council
Funding Amount
$463,652.00
Summary
I have pioneered the development of a robust body of evidence demonstrating the important role of diet in mental health and I am now recognised internationally as a research leader in this new field. The next important step is to translate this knowledge into new prevention and treatment strategies in order to address the substantial global burden of illness attributable to mental disorders.
Systems Immunology Of Antigen Specific T Cells: From Single-cell To Immune Protection
Funder
National Health and Medical Research Council
Funding Amount
$470,144.00
Summary
T cells are key for establishment of immune protection and object of ongoing research in vaccines and more recently immunotherapy against infections and some cancers. Their dynamics are complex and many mechanisms remain unknown that could be exploited for modern therapies. Here, in a systems approach I will combined single cell technologies, immunology and computational biology to identify the factors that determine the establishment of long term memory cells utilising a unique set of samples.
Understanding And Modulating The Human Immune System
Funder
National Health and Medical Research Council
Funding Amount
$470,144.00
Summary
T cells are the sentinels of our immune system continually scanning our tissue for abnormalities and eliminating threats in many forms. They are our second and last line of defence against microorganisms and cancer. Unfortunately, T cells can also cause harm through accidental crossreactvity or overzealous function. My work is directed at understanding how T cells work and how they can be controlled using drugs and gene therapy. If we can ‘tune’ the power of this master immune lineage we can unl
Understanding And Modulating Hyperinflammation Caused By Influenza Viruses
Funder
National Health and Medical Research Council
Funding Amount
$425,048.00
Summary
In humans, highly pathogenic influenza A virus (IAV) infections can be fatal, as the disease is untreatable with available vaccine or anti-viral drugs. My fellowship aims to advance our knowledge of the mechanisms by which the immune system induces and regulates inflammation during IAV infection, which can be both helpful and detrimental in fighting the infection. This is critical for identifying and developing new therapies for severe IAV infections in the future.
In Vivo Responses To Pathogen-derived Mediators Of Acute Inflammation
Funder
National Health and Medical Research Council
Funding Amount
$94,250.00
Summary
Sepsis causes large numbers of deaths worldwide. It is not known why some patients tolerate an infection and fully recover, while other patients with an equivalent infection are highly vulnerable to severe illness and death from sepsis. Heart failure is a common underlying condition in sepsis. This research will focus on how an infection can cause sudden cardiac death. It will have implications for care of patients with severe infection and also sudden infant death syndrome.